Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

Author(s):
Abubakar, M.; Chang-Claude, J.; Ali, H.R.; Chatterjee, N.; Coulson, P.; Daley, F.; Blows, F.; Benitez, J.; Milne, R.L.; Brenner, H.; Stegmaier, C.; Mannermaa, A.; Rudolph, A.; Sinn, P.; Couch, F.J.; Devilee, P. (0000-0002-8023-2009); Tollenaar, R.A.E.M. (0000-0002-6831-6082); Seynaeve, C.; Figueroa, J.; Lissowska, J.; Hewitt, S.; Hooning, M.J.; Hollestelle, A.; Foekens, R.; Koppert, L.B.; Bolla, M.K.; Wang, Q.; Jones, M.E.; Schoemaker, M.J.; Keeman, R.; Easton, D.F.; Swerdlow, A.J.; Sherman, M.E.; Schmidt, M.K.; Pharoah, P.D.; Garcia-Closas, M.; kConFab Investigators
Published
2018
Publication type
Article / Letter to editor
breast cancerepidemiologyobesitynulliparityhormone therapygradeKI67proliferation
Date issued
2018-08-15
Language
English
Is part of
International Journal of Cancer (2018), Vol. 143, no. 4, p. 746-757
hdl
1887/86418
doi
10.1002/ijc.31352